The Menopause Monitoring Profile is a comprehensive blood test designed to evaluate a woman’s hormonal balance, metabolic status, and bone health during the menopausal transition. It provides valuable insights into the severity of menopausal symptoms, progression of menopause, and related health risks such as osteoporosis and cardiovascular disease.
The profile typically covers;
Follicle Stimulating Hormone (FSH)
Estradiol (E2)
Calcium
Phosphorus
Lipid Profile (cholesterol and triglycerides)
This combination of tests helps track hormonal changes and assess a woman’s overall health status during and after menopause.
Indications for the Test
The Menopause Monitoring Profile is recommended for:
Women aged 40 and above experiencing:
Irregular or missed periods
Hot flashes or night sweats
Mood swings, fatigue, or sleep disturbances
Vaginal dryness or reduced libido
Women considering or currently undergoing Hormone Replacement Therapy (HRT)
Individuals with a family history of osteoporosis or heart disease
Patient Preparation
To ensure accurate results:
Fasting: Required for lipid profile (8–12 hours; water allowed)
Timing: For women still menstruating, test ideally on day 3–5 of the menstrual cycle
Medications: Speak with your doctor about temporarily pausing HRT or supplements
Sample collection: One blood sample is taken, preferably in the morning for hormonal accuracy
Reference Values
Typical reference ranges may vary by laboratory, but expected trends include:
FSH: Elevated (>25 IU/L) during menopause
Estradiol (E2): Decreased (<30 pg/mL)
Calcium & Phosphorus: Monitored for bone health stability
Lipid Profile: Elevated cholesterol or triglycerides may indicate increased cardiovascular risk
These values, interpreted alongside symptoms and clinical history, help determine menopausal status and guide management.
Interpretation of Results
High FSH and low estradiol levels typically confirm perimenopause or menopause
Changes in calcium and phosphorus may indicate bone density loss
Altered lipid levels can reflect increased risk for heart disease during postmenopause
Results are used to assess suitability for HRT, monitor symptom progression, and recommend preventive interventions
Turnaround Time
Results are usually available within 2 working days after sample collection.
Order Menopause Monitoring Profile in Kenya
To book your test, click the ‘Order Test’ button and add the Menopause Monitoring Profile to your cart.
You may also visit our laboratory located in Kilimani, Nairobi to initiate the testing process.
